Official UK visa sponsor profile for Exscientia AI Limited in Abingdon, including current register status, route details, and public company data.
Exscientian AI Limited is a UK-based artificial intelligence company specializing in discovery and development of novel pharmaceutical compounds and biological entities. Founded in 2012, the company focuses on leveraging advanced machine learning algorithms to accelerate drug design and optimization across various therapeutic areas. The core business revolves around providing comprehensive research services encompassing target identification, lead generation, medicinal chemistry optimization, and preclinical assessment. Exscientian AI distinguishes itself through its proprietary technology platform – “Exscientia” – which enables rapid screening of vast chemical spaces and facilitates the creation of novel drug candidates. The company’s expertise spans across diverse areas including oncology, immunology, neurology, and metabolic diseases. They actively monitor industry trends in pharmaceutical research, competitor activity, and market dynamics to inform strategic decision-making. Exscientian AI has a strong international presence with operations spanning Europe, North America, and Asia. Currently, the company is employing a team of highly skilled scientists and engineers dedicated to innovation. The company’s stock symbol is EXN on the London Stock Exchange (LSE: EXN). SIC Codes: - 72190: Other research and experimental development on natural sciences and engineering
Official UK visa sponsor profile for Exscientia AI Limited in Abingdon, including current register status, route details, and public company data.
Exscientian AI Limited is a UK-based artificial intelligence company specializing in discovery and development of novel pharmaceutical compounds and biological entities. Founded in 2012, the company focuses on leveraging advanced machine learning algorithms to accelerate drug design and optimization across various therapeutic areas. The core business revolves around providing comprehensive research services encompassing target identification, lead generation, medicinal chemistry optimization, and preclinical assessment. Exscientian AI distinguishes itself through its proprietary technology platform – “Exscientia” – which enables rapid screening of vast chemical spaces and facilitates the creation of novel drug candidates. The company’s expertise spans across diverse areas including oncology, immunology, neurology, and metabolic diseases. They actively monitor industry trends in pharmaceutical research, competitor activity, and market dynamics to inform strategic decision-making. Exscientian AI has a strong international presence with operations spanning Europe, North America, and Asia. Currently, the company is employing a team of highly skilled scientists and engineers dedicated to innovation. The company’s stock symbol is EXN on the London Stock Exchange (LSE: EXN). SIC Codes: - 72190: Other research and experimental development on natural sciences and engineering
Yes, Exscientia AI Limited is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
Exscientia AI Limited is classified under: Other research and experimental development on natural sciences and engineering.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.
Yes, Exscientia AI Limited is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
Exscientia AI Limited is classified under: Other research and experimental development on natural sciences and engineering.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.